- Report
- October 2023
- 185 Pages
Global
€4607EUR$4,795USD£3,939GBP
- Report
- December 2023
- 255 Pages
Global
From €4607EUR$4,795USD£3,939GBP
- Report
- December 2023
- 80 Pages
United States
From €2493EUR$2,595USD£2,132GBP
- Report
- February 2024
- 250 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- February 2024
- 250 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- January 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- April 2024
- 137 Pages
Global
From €3746EUR$3,899USD£3,203GBP
- Report
- January 2024
- 142 Pages
Global
From €3746EUR$3,899USD£3,203GBP
- Report
- November 2023
- 420 Pages
Global
From €3060EUR$3,185USD£2,616GBP
€4372EUR$4,550USD£3,738GBP
- Report
- November 2023
- 320 Pages
Global
From €3060EUR$3,185USD£2,616GBP
€4372EUR$4,550USD£3,738GBP
- Report
- April 2024
- 183 Pages
Global
From €4708EUR$4,900USD£4,025GBP
- Report
- October 2023
- 84 Pages
Global
From €4708EUR$4,900USD£4,025GBP
- Clinical Trials
- April 2024
- 90 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Report
- March 2024
- 200 Pages
Global
From €3987EUR$4,150USD£3,409GBP
- Report
- May 2020
- 117 Pages
Global
From €3987EUR$4,150USD£3,409GBP
- Report
- October 2018
- 288 Pages
Global
From €3987EUR$4,150USD£3,409GBP
- Report
- April 2023
- 100 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- April 2020
- 67 Pages
Global
From €4756EUR$4,950USD£4,066GBP
- Report
- January 2023
- 229 Pages
Middle East, Africa
From €2018EUR$2,100USD£1,725GBP
€2883EUR$3,000USD£2,464GBP
The antimalarial market is a subset of the infectious diseases drugs market, which focuses on the treatment and prevention of malaria. Antimalarial drugs are used to treat and prevent the spread of the Plasmodium parasite, which is responsible for the disease. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Common antimalarial drugs include chloroquine, artemisinin, and mefloquine.
In addition to antimalarial drugs, the market also includes insecticides, insect repellents, and other preventive measures. These products are used to reduce the risk of infection by controlling the mosquito population, which is the primary vector for the Plasmodium parasite.
Notable companies in the antimalarial market include GlaxoSmithKline, Sanofi, Novartis, and Merck. These companies produce a variety of antimalarial drugs, insecticides, and other preventive measures. Show Less Read more